Cargando…
Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial
BACKGROUND: Intra-arterial radioembolization with yttrium-90 microspheres ( (90)Y-RE) is an increasingly used therapy for patients with unresectable liver malignancies. Over the last decade, radioactive holmium-166 poly(L-lactic acid) microspheres ( (166)Ho-PLLA-MS) have been developed as a possible...
Autores principales: | Smits, Maarten LJ, Nijsen, Johannes FW, van den Bosch, Maurice AAJ, Lam, Marnix GEH, Vente, Maarten AD, Huijbregts, Julia E, van het Schip, Alfred D, Elschot, Mattijs, Bult, Wouter, de Jong, Hugo WAM, Meulenhoff, Pieter CW, Zonnenberg, Bernard A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903532/ https://www.ncbi.nlm.nih.gov/pubmed/20550679 http://dx.doi.org/10.1186/1756-9966-29-70 |
Ejemplares similares
-
MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation
por: van de Maat, Gerrit H., et al.
Publicado: (2012) -
Accuracy of SPECT/CT‐based lung dose calculation for Holmium‐166 hepatic radioembolization before OSEM convergence
por: van Nierop, Bastiaan J., et al.
Publicado: (2018) -
Quality of life in patients with liver tumors treated with holmium-166 radioembolization
por: van Roekel, Caren, et al.
Publicado: (2019) -
Holmium-166 Radioembolization: Current Status and Future Prospective
por: Stella, Martina, et al.
Publicado: (2022) -
Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model
por: Vente, M. A. D., et al.
Publicado: (2009)